Content
All Posts > Content under Pharma/Biotech
The Jobless Recovery
Article By:
Daniel Lacalle
Read
Sunday, August 9, 2020 7:05 AM EDT
Headline official unemployment rates are misleading due to different subsidies and furloughed jobs. If we use comparable figures, the United States inactive share of the labor force is significantly smaller than the same figure in the Eurozone.
Bulls And Bears Of The Week: Apple, Ford, Merck, Uber And More
Article By:
Benzinga
Read
Saturday, August 8, 2020 6:30 PM EDT
A July employment report that was better than feared helped U.S. indices end higher, led by the Nasdaq's almost 4% gain. Earnings reporting season has peaked and was not as bad as expected, though many have yet to step into the earnings spotlight.
Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine
Article By:
ChinaBio® Today
Read
Saturday, August 8, 2020 12:13 PM EDT
BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture, and market AstraZeneca's COVID-19 vaccine in China. Biogen announced a $2 billion deal to partner Denali Therapeutics' potential Parkinson's Disease therapy.
Jeff Bezos Sells More Than $3bn In Amazon Stock
Article By:
Adam Vettese
Read
Thursday, August 6, 2020 6:30 AM EDT
Amazon founder and CEO Jeff Bezos has sold more than $3bn worth of Amazon stock, after the company’s share price surged 36% in the past three months and 73% in the year-to-date.
In this article: BMY, TMUS, UBER, AMZN Also: BA, DIS, BHPBF, CCHBF, EVRZF, FNLPF, GLCNF, SAXPY, WIMHF, REGN, DIA, GLD, SPY, META, SPX, AAL, BITCOMP, NGLOY, POYYF
Market Briefing For Thursday, August 6
Article By:
Gene Inger
Read
Thursday, August 6, 2020 2:37 AM EDT
An economic chasm risks occurring right when COVID-19 will collide with seasonal influenza, with complete confusion occurring amidst the public, if nothing's achieved in the very short time-frame that remains.
Regeneron (REGN) Tops Q2 Earnings And Revenue Estimates
Article By:
Zacks Investment Research
Read
Wednesday, August 5, 2020 10:09 AM EDT
Regeneron came out with quarterly earnings of $7.16 per share.
In this article: REGN
Korea Stock: Sinil Pharmaceutical
Article By:
Andrew Stotz
Read
Wednesday, August 5, 2020 6:54 AM EDT
Sinil Pharmaceutical Company Limited manufactures pharmaceutical products. It operates through the following business divisions: Drugs, Health Functional Food, Cosmetics, Real Estate, and Quasi-Drugs.
Cannabis Central: Another Day, Another 2.7% Gain
Article By:
Lorimer Wilson
Read
Wednesday, August 5, 2020 4:10 AM EDT
The Pot Stock Index of the 25 pure-play cannabis stocks that consistently trade above US$1/share matched Monday's 2.7% gain. 14 of the constituents went up, 2 had No Change in price and 2 of the 3 associated sector categories also went up.
Market Briefing For Wednesday, August 5
Article By:
Gene Inger
Read
Wednesday, August 5, 2020 2:12 AM EDT
The pandemic is not over. There is also an epidemic of violence by those who do not grasp the importance of both freedom of expression, free-market capitalism, and what some allege is now 'insurrection' requiring Federal intervention.
Incyte Q2 Earnings And Revenues Beat Estimates
Article By:
Zacks Investment Research
Read
Tuesday, August 4, 2020 9:55 AM EDT
Incyte came out with quarterly earnings of $1.24 per share.
In this article: INCY
Cannabis Central: Check Out Australia's 16 Cannabis Companies & How To Buy Them
Article By:
Lorimer Wilson
Read
Tuesday, August 4, 2020 7:46 AM EDT
It is forecasted that the Oceania region will be worth A$1.55B by 2024 with 79% of that being comprised within Australia, so an Australian Cannabis Index has been created to track the performance of the 16 cannabis companies operating in the country.